Latest Advances

  • Journal: Neurologia (Barcelona, Spain)
  • Published —
Non-inflammatory causes of emergency consultation in patients with multiple sclerosis.
  • Journal: Molecules (Basel, Switzerland)
  • Published —
CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.
  • Journal: Journal of managed care & specialty pharmacy
  • Published —
Association between multiple sclerosis disease severity and adherence to disease-modifying therapies.
  • Condition: Patients with Resistant Multiple Sclerosis (MS) Spasticity in Belgium
  • Journal: BMC neurology
  • Treatment Used: Sativex® (Nabiximols) Cannabinoid Oromucosal Spray
  • Number of Patients: 276
  • Published —
This study evaluated outcomes of a cannabinoid oromucosal spray (Sativex®; nabiximols) in patients with resistant multiple sclerosis (MS) spasticity in Belgium.
  • Condition: Patients of African Descent with Relapsing Multiple Sclerosis (MS)
  • Journal: Multiple sclerosis and related disorders
  • Treatment Used: Ocrelizumab vs. Interferon Beta-1a
  • Number of Patients: 1656
  • Published —
This study evaluated the safety and effectiveness of ocrelizumab versus interferon beta-1a in patients of African descent with relapsing multiple sclerosis (MS).
  • Journal: CNS spectrums
  • Published —
Othello Syndrome: Delusional Disorder - Jealous Type ≠ Violence.
  • Journal: The American journal of case reports
  • Published —
Unilateral Optic Neuritis Associated with SARS-CoV-2 Infection: A Rare Complication.
  • Condition: Patients with Multiple Sclerosis (MS) During COVID-19 Pandemic
  • Journal: Medicina (Kaunas, Lithuania)
  • Treatment Used: Modern Rehabilitation Technologies
  • Number of Patients: 854
  • Published —
This review of the literature analyzed the effectiveness of using new technologies for the rehabilitation of patients with multiple sclerosis (MS) during the COVID-19 pandemic.
  • Condition: Secondary Progressive Multiple Sclerosis
  • Journal: Neurology
  • Treatment Used: Repurposing Domperidone
  • Number of Patients: 110
  • Published —
This study assessed treatment with domperidone in patients with secondary progressive multiple sclerosis (SPMS).
Showing 1-12 of 472